(Q40228622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

The chemotherapeutic agent VP16 increases the stability of HB-EGF mRNA by a mechanism involving the 3'-UTR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Dorthe Ornskov

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ebba Nexo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

16 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

3651-3658

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

The ErbB signaling network: receptor heterodimerization in development and cancer

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Neuregulins: functions, forms, and signaling strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

The ErbB receptors and their role in cancer progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Activation of BAD by therapeutic inhibition of epidermal growth factor receptor and transactivation by insulin-like growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Upregulation of endogenous heparin-binding EGF-like growth factor and its role as a survival factor in skeletal myotubes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

7 January 2021

HuR and mRNA stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development. A potential role of PDX-1 in transcriptional activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Real-time polymerase chain reaction is a sensitive and precise method for quantifying transcription from reporter plasmids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

HuR regulates p21 mRNA stabilization by UV light

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Role of the RNA-binding protein HuR in colon carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.08.007

10.1016/J.YEXCR.2006.08.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16996055%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference